{"nersets":[[{"setid":"PMC1865122","drugname":"rifampin","startOffset":"479","endOffset":"487","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"hosh (80 mg) supplement for 14 days. Subjects also received ","suffix":" (600 mg) and clarithromycin (1000 mg) for 7 days as positiv","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"743","endOffset":"751","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":" control period. The effects of milk thistle, black cohosh, ","suffix":", and clarithromycin on midazolam pharmacokinetics were dete","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"879","endOffset":"887","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"sing noncompartmental techniques. Unlike those observed for ","suffix":" and clarithromycin, midazolam pharmacokinetics were unaffec","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"42","endOffset":"50","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"The effect of milk thistle, black cohosh, ","suffix":" and clarithromycin on midazolam pharmacokinetics was evalua","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"327","endOffset":"335","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"on/medication” refers either to milk thistle, black cohosh, ","suffix":", or clarithromycin.) Each supplementation phase (milk thist","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"327","endOffset":"335","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"on/medication” refers either to milk thistle, black cohosh, ","suffix":", or clarithromycin.) Each supplementation phase (milk thist","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"459","endOffset":"467","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"r black cohosh) lasted 14 days while each medication phase (","suffix":" or clarithromycin) was of 7 days duration. Each supplementa","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"1016","endOffset":"1024","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ry for providing products of high quality and consistency.) ","suffix":" (Rifadin","exact":"Rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"109","endOffset":"117","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","prefix":"typic ratios (1-hydroxymidazolam/midazolam) for CYP3A4. (A) ","suffix":", (B) Clarithromycin, (C) Milk thistle, (D) Black cohosh. Gr","exact":"Rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"439","endOffset":"447","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[1]","prefix":"oloration of the urine were common conditions reported with ","suffix":" use. Three subjects noted an increase in headaches while ta","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"213","endOffset":"221","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[2]","prefix":"ticeable effect on the duration of MDZ-induced sleep. After ","suffix":", however, most subjects either did not sleep or their sleep","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"31","endOffset":"39","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[3]","prefix":"The effects of clarithromycin, ","suffix":", milk thistle, and black cohosh on serum MDZ concentration ","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"71","endOffset":"79","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","prefix":"oncentration-time profiles before and after clarithromycin. ","suffix":", milk thistle and black cohosh. Black squares = baseline va","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"361","endOffset":"369","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[4]","prefix":"extent of CYP3A induction (i.e., change in pre- versus post-","suffix":" CL/F/kg) or inhibition (i.e. change in pre- versus post-cla","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"109","endOffset":"117","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","prefix":"typic ratios (1-hydroxymidazolam/midazolam) for CYP3A4. (A) ","suffix":", (B) Clarithromycin, (C) Milk thistle, (D) Black cohosh. Gr","exact":"Rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"472","endOffset":"480","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"nistration of clarithromycin, a known CYP3A4 inhibitor, and ","suffix":", a recognized inducer of CYP3A4 expression. In addition, ou","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifampin","startOffset":"47","endOffset":"55","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"In conclusion, when compared to the effects of ","suffix":" and clarithromycin, the specific brand of milk thistle and ","exact":"rifampin"},{"setid":"PMC1865122","drugname":"rifadin","startOffset":"1026","endOffset":"1033","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"viding products of high quality and consistency.) Rifampin (","suffix":"","exact":"Rifadin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"302","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"o a clinically recognized inducer, rifampin, and inhibitor, ","suffix":". Healthy volunteers were randomly assigned to receive a sta","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"173","endOffset":"187","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":" of a milk thistle and black cohosh product to rifampin and ","suffix":"","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"302","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"o a clinically recognized inducer, rifampin, and inhibitor, ","suffix":". Healthy volunteers were randomly assigned to receive a sta","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"501","endOffset":"515","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"t for 14 days. Subjects also received rifampin (600 mg) and ","suffix":" (1000 mg) for 7 days as positive controls for CYP3A inducti","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"757","endOffset":"771","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"d. The effects of milk thistle, black cohosh, rifampin, and ","suffix":" on midazolam pharmacokinetics were determined using noncomp","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"892","endOffset":"906","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"rtmental techniques. Unlike those observed for rifampin and ","suffix":", midazolam pharmacokinetics were unaffected by milk thistle","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"55","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"The effect of milk thistle, black cohosh, rifampin and ","suffix":" on midazolam pharmacokinetics was evaluated individually on","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"55","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","prefix":"Midazolam concentration-time profiles before and after ","suffix":". rifampin, milk thistle and black cohosh. Black squares = b","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"60","endOffset":"74","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"In conclusion, when compared to the effects of rifampin and ","suffix":", the specific brand of milk thistle and black cohosh supple","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"161","endOffset":"175","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[40]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[40]/span[1]","prefix":"l and hepatic CP3A to the interaction between midazolam and ","suffix":". ","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"757","endOffset":"771","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"d. The effects of milk thistle, black cohosh, rifampin, and ","suffix":" on midazolam pharmacokinetics were determined using noncomp","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"892","endOffset":"906","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"rtmental techniques. Unlike those observed for rifampin and ","suffix":", midazolam pharmacokinetics were unaffected by milk thistle","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"55","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"The effect of milk thistle, black cohosh, rifampin and ","suffix":" on midazolam pharmacokinetics was evaluated individually on","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"340","endOffset":"354","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"” refers either to milk thistle, black cohosh, rifampin, or ","suffix":".) Each supplementation phase (milk thistle or black cohosh)","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"471","endOffset":"485","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"sh) lasted 14 days while each medication phase (rifampin or ","suffix":") was of 7 days duration. Each supplementation/medication ph","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"173","endOffset":"187","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":" of a milk thistle and black cohosh product to rifampin and ","suffix":"","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"302","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"o a clinically recognized inducer, rifampin, and inhibitor, ","suffix":". Healthy volunteers were randomly assigned to receive a sta","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"501","endOffset":"515","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"t for 14 days. Subjects also received rifampin (600 mg) and ","suffix":" (1000 mg) for 7 days as positive controls for CYP3A inducti","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"757","endOffset":"771","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"d. The effects of milk thistle, black cohosh, rifampin, and ","suffix":" on midazolam pharmacokinetics were determined using noncomp","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"892","endOffset":"906","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"rtmental techniques. Unlike those observed for rifampin and ","suffix":", midazolam pharmacokinetics were unaffected by milk thistle","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"55","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"The effect of milk thistle, black cohosh, rifampin and ","suffix":" on midazolam pharmacokinetics was evaluated individually on","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"55","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","prefix":"Midazolam concentration-time profiles before and after ","suffix":". rifampin, milk thistle and black cohosh. Black squares = b","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"60","endOffset":"74","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"In conclusion, when compared to the effects of rifampin and ","suffix":", the specific brand of milk thistle and black cohosh supple","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"161","endOffset":"175","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[40]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[40]/span[1]","prefix":"l and hepatic CP3A to the interaction between midazolam and ","suffix":". ","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"323","endOffset":"337","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[1]","prefix":"complaints of a metallic taste were frequently noted during ","suffix":" phases. Mild indigestion and reddish discoloration of the u","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"312","endOffset":"326","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[2]","prefix":" did not sleep or their sleep time was less than 0.5 hours. ","suffix":" increased the average sleep time for all subjects to 3–4 ho","exact":"Clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"15","endOffset":"29","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[3]","prefix":"The effects of ","suffix":", rifampin, milk thistle, and black cohosh on serum MDZ conc","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"55","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","prefix":"Midazolam concentration-time profiles before and after ","suffix":". rifampin, milk thistle and black cohosh. Black squares = b","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"426","endOffset":"440","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/p[4]","prefix":"pin CL/F/kg) or inhibition (i.e. change in pre- versus post-","suffix":" Cl/F/kg) were observed.","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"123","endOffset":"137","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","prefix":"1-hydroxymidazolam/midazolam) for CYP3A4. (A) Rifampin, (B) ","suffix":", (C) Milk thistle, (D) Black cohosh. Gray circles = individ","exact":"Clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"426","endOffset":"440","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"Z pharmacokinetics observed following the administration of ","suffix":", a known CYP3A4 inhibitor, and rifampin, a recognized induc","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"clarithromycin","startOffset":"60","endOffset":"74","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"In conclusion, when compared to the effects of rifampin and ","suffix":", the specific brand of milk thistle and black cohosh supple","exact":"clarithromycin"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"608","endOffset":"617","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":" controls for CYP3A induction and inhibition, respectively. ","suffix":" was administered orally before and after each supplementati","exact":"Midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"775","endOffset":"784","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"milk thistle, black cohosh, rifampin, and clarithromycin on ","suffix":" pharmacokinetics were determined using noncompartmental tec","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"908","endOffset":"917","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"ues. Unlike those observed for rifampin and clarithromycin, ","suffix":" pharmacokinetics were unaffected by milk thistle or black c","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"948","endOffset":"957","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":" these restrictions was further emphasized five days before ","suffix":" administration. Subjects were also instructed to refrain fr","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"73","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":" milk thistle, black cohosh, rifampin and clarithromycin on ","suffix":" pharmacokinetics was evaluated individually on four separat","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"135","endOffset":"144","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"s for Medical Sciences General Clinical Research Center for ","suffix":" administration and blood sampling. Prior to midazolam admin","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"189","endOffset":"198","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"r for midazolam administration and blood sampling. Prior to ","suffix":" administration subjects were weighed and questioned about t","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"552","endOffset":"561","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"eter into a peripheral vein of the forearm, an oral dose of ","suffix":" (8 mg, Bedford Laboratories, Bedford, OH) was administered ","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"665","endOffset":"674","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"as administered with 240 ml of water. Throughout the study, ","suffix":" doses were administered 24 hours before the start of each s","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"923","endOffset":"932","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":" at 0.25, 0.50, 0.75, 1, 1.5, 2, 3, 4, 5, and 6 hours after ","suffix":" administration. Blood samples were allowed to clot for 30 m","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"1214","endOffset":"1223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":" respiration rate was monitored at 0.5, 1, and 2 hours post-","suffix":" administration. Four hours after dosing, subjects received ","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"44","endOffset":"53","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[7]/p[1]","prefix":"An absence of botanical-mediated effects on ","suffix":" pharmacokinetics could stem from products exhibiting poor d","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"0","endOffset":"9","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[2]/span[1]","prefix":"","suffix":" concentration-time profiles before and after clarithromycin","exact":"Midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"0","endOffset":"9","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[2]/span[1]","prefix":"","suffix":" pharmacokinetic parameters before and after supplementation","exact":"Midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"775","endOffset":"784","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"milk thistle, black cohosh, rifampin, and clarithromycin on ","suffix":" pharmacokinetics were determined using noncompartmental tec","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"908","endOffset":"917","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/p[1]","prefix":"ues. Unlike those observed for rifampin and clarithromycin, ","suffix":" pharmacokinetics were unaffected by milk thistle or black c","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"948","endOffset":"957","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":" these restrictions was further emphasized five days before ","suffix":" administration. Subjects were also instructed to refrain fr","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"73","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":" milk thistle, black cohosh, rifampin and clarithromycin on ","suffix":" pharmacokinetics was evaluated individually on four separat","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"135","endOffset":"144","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"s for Medical Sciences General Clinical Research Center for ","suffix":" administration and blood sampling. Prior to midazolam admin","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"189","endOffset":"198","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"r for midazolam administration and blood sampling. Prior to ","suffix":" administration subjects were weighed and questioned about t","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"552","endOffset":"561","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"eter into a peripheral vein of the forearm, an oral dose of ","suffix":" (8 mg, Bedford Laboratories, Bedford, OH) was administered ","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"665","endOffset":"674","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"as administered with 240 ml of water. Throughout the study, ","suffix":" doses were administered 24 hours before the start of each s","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"923","endOffset":"932","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":" at 0.25, 0.50, 0.75, 1, 1.5, 2, 3, 4, 5, and 6 hours after ","suffix":" administration. Blood samples were allowed to clot for 30 m","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"1214","endOffset":"1223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":" respiration rate was monitored at 0.5, 1, and 2 hours post-","suffix":" administration. Four hours after dosing, subjects received ","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"44","endOffset":"53","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[7]/p[1]","prefix":"An absence of botanical-mediated effects on ","suffix":" pharmacokinetics could stem from products exhibiting poor d","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"72","endOffset":"81","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","prefix":"f pre- and post-supplementation phenotypic ratios (1-hydroxy","suffix":"/midazolam) for CYP3A4. (A) Rifampin, (B) Clarithromycin, (C","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"82","endOffset":"91","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[2]/span[1]","prefix":" post-supplementation phenotypic ratios (1-hydroxymidazolam/","suffix":") for CYP3A4. (A) Rifampin, (B) Clarithromycin, (C) Milk thi","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"25","endOffset":"34","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","prefix":"Plot of 1-hour 1′-hydroxy","suffix":"/midazolam phenotypic ratios versus midazolam oral clearance","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"35","endOffset":"44","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","prefix":"Plot of 1-hour 1′-hydroxymidazolam/","suffix":" phenotypic ratios versus midazolam oral clearance (CL/F/kg)","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"70","endOffset":"79","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","prefix":"hour 1′-hydroxymidazolam/midazolam phenotypic ratios versus ","suffix":" oral clearance (CL/F/kg).","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"217","endOffset":"226","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"study produced no significant changes in the disposition of ","suffix":", a clinically recognized CYP3A substrate. Accordingly, thes","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"116","endOffset":"125","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[37]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[37]/span[1]","prefix":"le plasma sampling to predict oral clearance of CYP3A probe ","suffix":". ","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"138","endOffset":"147","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[38]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[38]/span[1]","prefix":"n GR, Bertino JS. Single plasma concentrations of 1′-hydroxy","suffix":" or the ratio of 1′-hydroxymidazolam:midazolam do not predic","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"174","endOffset":"183","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[38]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[38]/span[1]","prefix":"entrations of 1′-hydroxymidazolam or the ratio of 1′-hydroxy","suffix":":midazolam do not predict midazolam clearance in healthy sub","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"184","endOffset":"193","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[38]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[38]/span[1]","prefix":" of 1′-hydroxymidazolam or the ratio of 1′-hydroxymidazolam:","suffix":" do not predict midazolam clearance in healthy subjects. ","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"209","endOffset":"218","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[38]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[38]/span[1]","prefix":"r the ratio of 1′-hydroxymidazolam:midazolam do not predict ","suffix":" clearance in healthy subjects. ","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"147","endOffset":"156","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[40]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[40]/span[1]","prefix":"n of intestinal and hepatic CP3A to the interaction between ","suffix":" and clarithromycin. ","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"35","endOffset":"44","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","prefix":"Plot of 1-hour 1′-hydroxymidazolam/","suffix":" phenotypic ratios versus midazolam oral clearance (CL/F/kg)","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"70","endOffset":"79","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[4]/div[1]/div[2]/span[1]","prefix":"hour 1′-hydroxymidazolam/midazolam phenotypic ratios versus ","suffix":" oral clearance (CL/F/kg).","exact":"midazolam"},{"setid":"PMC1865122","drugname":"midazolam","startOffset":"217","endOffset":"226","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"study produced no significant changes in the disposition of ","suffix":", a clinically recognized CYP3A substrate. Accordingly, thes","exact":"midazolam"},{"setid":"PMC1865122","drugname":"silibinin","startOffset":"193","endOffset":"202","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","prefix":" of the flavanolignans taxifolin, silychristin, silydianin, ","suffix":" A, and silibinin B were purchased from ChromaDex, Inc. (San","exact":"silibinin"},{"setid":"PMC1865122","drugname":"silibinin","startOffset":"210","endOffset":"219","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","prefix":"gnans taxifolin, silychristin, silydianin, silibinin A, and ","suffix":" B were purchased from ChromaDex, Inc. (Santa Ana, CA, USA).","exact":"silibinin"},{"setid":"PMC1865122","drugname":"silibinin","startOffset":"614","endOffset":"623","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"ot support previous in vitro findings that silymarin (i.e., ","suffix":" A, silibinin B silidianin, silichristin, and taxifolin) inh","exact":"silibinin"},{"setid":"PMC1865122","drugname":"silibinin","startOffset":"627","endOffset":"636","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"evious in vitro findings that silymarin (i.e., silibinin A, ","suffix":" B silidianin, silichristin, and taxifolin) inhibits CYP3A4 ","exact":"silibinin"},{"setid":"PMC1865122","drugname":"silibinin","startOffset":"562","endOffset":"571","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"ine separate milk thistle products found that the amount of ","suffix":" released over one hour into an aqueous buffered solution (p","exact":"silibinin"},{"setid":"PMC1865122","drugname":"silydianin","startOffset":"181","endOffset":"191","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","prefix":"al standards of the flavanolignans taxifolin, silychristin, ","suffix":", silibinin A, and silibinin B were purchased from ChromaDex","exact":"silydianin"},{"setid":"PMC1865122","drugname":"silidianin","startOffset":"639","endOffset":"649","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"tro findings that silymarin (i.e., silibinin A, silibinin B ","suffix":", silichristin, and taxifolin) inhibits CYP3A4 activity, at ","exact":"silidianin"},{"setid":"PMC1865122","drugname":"taxifolin","startOffset":"156","endOffset":"165","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","prefix":"pounds” by HPLC. Analytical standards of the flavanolignans ","suffix":", silychristin, silydianin, silibinin A, and silibinin B wer","exact":"taxifolin"},{"setid":"PMC1865122","drugname":"taxifolin","startOffset":"669","endOffset":"678","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":".e., silibinin A, silibinin B silidianin, silichristin, and ","suffix":") inhibits CYP3A4 activity, at least not in the context of t","exact":"taxifolin"},{"setid":"PMC1865122","drugname":"silymarin","startOffset":"597","endOffset":"606","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":" our results do not support previous in vitro findings that ","suffix":" (i.e., silibinin A, silibinin B silidianin, silichristin, a","exact":"silymarin"},{"setid":"PMC1865122","drugname":"silymarin","startOffset":"968","endOffset":"977","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"that in vitro studies demonstrating an inhibitory effect of ","suffix":" on CYP3A4 activity have utilized solubilizing agents (e.g.,","exact":"silymarin"},{"setid":"PMC1865122","drugname":"silymarin","startOffset":"422","endOffset":"431","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"heless, bioavailability and dissolution characteristics for ","suffix":"-containing products have been shown to vary widely. An eval","exact":"silymarin"},{"setid":"PMC1865122","drugname":"caffeine","startOffset":"762","endOffset":"770","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":"line. All subjects were instructed to abstain from alcohol, ","suffix":", fruit juices, cruciferous vegetables, and charbroiled meat","exact":"caffeine"},{"setid":"PMC1865122","drugname":"sodium acetate","startOffset":"15","endOffset":"29","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","prefix":"500 μL of 0.2M ","suffix":" (pH 4.75) was added to each 250 μL serum aliquot. 250 μL of","exact":"sodium acetate"},{"setid":"PMC1865122","drugname":"acetonitrile","startOffset":"307","endOffset":"319","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[3]","prefix":"f 0.2 mL/min using a 4-min. linear gradient from 30% to 80% ","suffix":":ammonium formate (5 mM pH 3.0). Analytes were converted to ","exact":"acetonitrile"},{"setid":"PMC1865122","drugname":"silychristin","startOffset":"167","endOffset":"179","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[5]/p[1]","prefix":"HPLC. Analytical standards of the flavanolignans taxifolin, ","suffix":", silydianin, silibinin A, and silibinin B were purchased fr","exact":"silychristin"},{"setid":"PMC1865122","drugname":"lecithin","startOffset":"98","endOffset":"106","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"resent study was formulated with soybean oil, glycerin, and ","suffix":" in a soft gelatin capsule, and upon disintegration the cont","exact":"lecithin"},{"setid":"PMC1865122","drugname":"gelatin","startOffset":"117","endOffset":"124","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"rmulated with soybean oil, glycerin, and lecithin in a soft ","suffix":" capsule, and upon disintegration the contents appeared to r","exact":"gelatin"},{"setid":"PMC1865122","drugname":"dmso","startOffset":"62","endOffset":"66","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","prefix":"cent in vitro findings demonstrate that, in the presence of ","suffix":", black cohosh extracts or individual triterpene glycosides ","exact":"DMSO"},{"setid":"PMC1865122","drugname":"dmso","startOffset":"62","endOffset":"66","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","prefix":"cent in vitro findings demonstrate that, in the presence of ","suffix":", black cohosh extracts or individual triterpene glycosides ","exact":"DMSO"},{"setid":"PMC1865122","drugname":"bergamottin","startOffset":"398","endOffset":"409","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"e two phytochemicals primarily responsible for this effect, ","suffix":" and 6′,7′-dihydroxybergamottin, do not attain measurable co","exact":"bergamottin"}],[{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"203","endOffset":"215","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" identical in both studies. The subjects took either 100 mg ","suffix":" or matched placebo orally once daily for 4 days. On day 4, ","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"405","endOffset":"417","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"concentrations of fluvastatin, lovastatin, lovastatin acid, ","suffix":" and hydroxyitraconazole were determined up to 24 h.","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"0","endOffset":"12","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"","suffix":" had no significant effect on the ","exact":"Itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"0","endOffset":"12","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"","suffix":", even at a small dosage of 100 mg daily, greatly elevated p","exact":"Itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"210","endOffset":"222","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" Lovastatin should therefore not be used concomitantly with ","suffix":" and other potent CYP3A4 inhibitors, or the dosage of lovast","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"421","endOffset":"433","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"vastatin concentrations were not significantly increased by ","suffix":", indicating that fluvastatin has much less potential than l","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"457","endOffset":"469","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"vastatin concentrations were not significantly increased by ","suffix":", indicating that fluvastatin has much less potential than l","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"548","endOffset":"560","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"han lovastatin for clinically significant interactions with ","suffix":" and other CYP3A4 inhibitors.","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"584","endOffset":"596","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"han lovastatin for clinically significant interactions with ","suffix":" and other CYP3A4 inhibitors.","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"26","endOffset":"38","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"fluvastatin, interaction, ","suffix":", lovastatin, pharmacokinetics","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"78","endOffset":"90","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[2]","prefix":" lovastatin and, for example, cyclosporine, erythromycin or ","suffix":" is associated with a considerably increased risk of skeleta","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"230","endOffset":"242","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ical in both studies. The subjects were given either 100 mg ","suffix":" (Sporanox, Janssen, Beerse, Belgium) or matched placebo ora","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"608","endOffset":"620","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"th 150 ml water at 09.00 h, i.e. 1 h after the last dose of ","suffix":". The subjects fasted for 1 h before administration of fluva","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"38","endOffset":"50","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"To assess the comparability of plasma ","suffix":" and hydroxyitraconazole levels between the lovastatin and f","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"137","endOffset":"149","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"vels between the lovastatin and fluvastatin studies, plasma ","suffix":" and hydroxyitraconazole concentrations were determined in a","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"250","endOffset":"262","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"ere determined in all samples, i.e. from 1 h after the last ","suffix":" dose on day 4 up to 25 h. Itraconazole and hydroxyitraconaz","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"289","endOffset":"301","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"m 1 h after the last itraconazole dose on day 4 up to 25 h. ","suffix":" and hydroxyitraconazole concentrations were determined by h","exact":"Itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"18","endOffset":"30","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[1]","prefix":"Pretreatment with ","suffix":" had no significant effect on the ","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"139","endOffset":"151","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[1]/div[2]/span[1]","prefix":"after a 40 mg oral dose, following pretreatment with 100 mg ","suffix":" (closed circles) or placebo (open circles) once daily for 4","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"211","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[2]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[2]/div[1]/div[2]/span[1]","prefix":"s (study II), following pretreatment with placebo or 100 mg ","suffix":" once daily for 4 days.","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"0","endOffset":"12","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","prefix":"","suffix":" considerably increased the plasma concentrations of both lo","exact":"Itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"180","endOffset":"192","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"oral dose of lovastatin, following pretreatment with 100 mg ","suffix":" (closed circles) or placebo (open circles) once daily","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"34","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","prefix":"The mean plasma concentrations of ","suffix":" and its active metabolite hydroxyitraconazole on the day of","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"98","endOffset":"110","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[7]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[7]/span[1]","prefix":"the coadministration of lovastatin and the antifungal agent ","suffix":". ","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"25","endOffset":"37","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","prefix":"Plasma concentrations of ","suffix":" (open circles, fluvastatin study; closed circles, lovastati","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"225","endOffset":"237","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","prefix":" closed triangles, lovastatin study) after intake of 100 mg ","suffix":" orally once daily","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"184","endOffset":"196","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"tatin acid, are greatly increased by a daily dose of 100 mg ","suffix":". By contrast, itraconazole had no significant effect on pla","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"211","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"reased by a daily dose of 100 mg itraconazole. By contrast, ","suffix":" had no significant effect on plasma fluvastatin concentrati","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"352","endOffset":"364","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"ver, the half-life of fluvastatin was slightly prolonged by ","suffix":", but this should not have any clinical relevance. The incre","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"467","endOffset":"479","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"evance. The increase in the total AUC of lovastatin acid by ","suffix":" was, on an average, 15-fold, but showed marked interindivid","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"554","endOffset":"566","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"rage, 15-fold, but showed marked interindividual variation. ","suffix":" appeared to have a similar effect on the total AUC of lovas","exact":"Itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"47","endOffset":"59","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","prefix":"In a previous study, a 4-day pretreatment with ","suffix":", 200 mg daily, increased the AUC of lovastatin and lovastat","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"33","endOffset":"45","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"Considering the marked effect of ","suffix":" 100 mg daily on plasma lovastatin and lovastatin acid conce","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"279","endOffset":"291","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"ction would occur between fluvastatin and higher dosages of ","suffix":". In a recent study, AUC values for fluvastatin were about 2","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"55","endOffset":"67","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"In conclusion, the results of this study indicate that ","suffix":", even at a dosage of 100 mg daily, greatly elevates plasma ","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"421","endOffset":"433","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"vastatin concentrations were not significantly increased by ","suffix":", indicating that fluvastatin has much less potential than l","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"457","endOffset":"469","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"vastatin concentrations were not significantly increased by ","suffix":", indicating that fluvastatin has much less potential than l","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"548","endOffset":"560","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"han lovastatin for clinically significant interactions with ","suffix":" and other CYP3A4 inhibitors.","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"itraconazole","startOffset":"584","endOffset":"596","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"han lovastatin for clinically significant interactions with ","suffix":" and other CYP3A4 inhibitors.","exact":"itraconazole"},{"setid":"PMC1873980","drugname":"sporanox","startOffset":"244","endOffset":"252","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"tudies. The subjects were given either 100 mg itraconazole (","suffix":", Janssen, Beerse, Belgium) or matched placebo orally once d","exact":"Sporanox"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"55","endOffset":"66","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"The effects of itraconazole on the pharmacokinetics of ","suffix":" and lovastatin, two inhibitors of HMG-CoA reductase with di","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"281","endOffset":"292","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"tched placebo orally once daily for 4 days. On day 4, 40 mg ","suffix":" or 40 mg lovastatin was administered orally. Plasma concent","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"363","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"ovastatin was administered orally. Plasma concentrations of ","suffix":", lovastatin, lovastatin acid, itraconazole and hydroxyitrac","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"358","endOffset":"369","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"reatly reduced while using a CYP3A4 inhibitor. In contrast, ","suffix":" concentrations were not significantly increased by itracona","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"451","endOffset":"462","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"ot significantly increased by itraconazole, indicating that ","suffix":" has much less potential than lovastatin for clinically sign","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"487","endOffset":"498","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"ot significantly increased by itraconazole, indicating that ","suffix":" has much less potential than lovastatin for clinically sign","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", interaction, itraconazole, lovastatin, pharmacokinetics","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","prefix":"","suffix":" and lovastatin are inhibitors of 3-hydroxy-3-methylglutaryl","exact":"Fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"43","endOffset":"54","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":"Ten healthy volunteers participated in the ","suffix":" study (five women and five men; age range, 20–25 years; wei","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"670","endOffset":"681","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":"ere using oral contraceptive steroids in the lovastatin and ","suffix":" studies, respectively.","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", interaction, itraconazole, lovastatin, pharmacokinetics","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"356","endOffset":"367","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"bo orally once daily at 08.00 h for 4 days. On day 4, 40 mg ","suffix":" (one Canef 40 mg capsule, Astra Ltd, Kirkkonummi, Finland) ","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"675","endOffset":"686","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"azole. The subjects fasted for 1 h before administration of ","suffix":" or lovastatin. A warm standard meal was served 4 h and a li","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"774","endOffset":"785","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ard meal was served 4 h and a light standard meal 8 h after ","suffix":" or lovastatin intake. The subjects were not allowed to drin","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"87","endOffset":"98","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"s cannulated and timed blood samples were drawn just before ","suffix":" or lovastatin was administered and 0.5, 1, 2, 3, 4, 6, 8, 1","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[2]","prefix":"","suffix":" concentrations were determined by h.p.l.c. using automated ","exact":"Fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"109","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"e and hydroxyitraconazole levels between the lovastatin and ","suffix":" studies, plasma itraconazole and hydroxyitraconazole concen","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"The pharmacokinetics of ","suffix":", lovastatin and lovastatin acid were characterized, as appr","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"61","endOffset":"72","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":"ifferent effects of itraconazole on the pharmacokinetics of ","suffix":" and lovastatin","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"55","endOffset":"66","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"The effects of itraconazole on the pharmacokinetics of ","suffix":" and lovastatin, two inhibitors of HMG-CoA reductase with di","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"363","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"ovastatin was administered orally. Plasma concentrations of ","suffix":", lovastatin, lovastatin acid, itraconazole and hydroxyitrac","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", interaction, itraconazole, lovastatin, pharmacokinetics","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"675","endOffset":"686","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"azole. The subjects fasted for 1 h before administration of ","suffix":" or lovastatin. A warm standard meal was served 4 h and a li","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"The pharmacokinetics of ","suffix":", lovastatin and lovastatin acid were characterized, as appr","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"25","endOffset":"36","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[1]/div[2]/span[1]","prefix":"Plasma concentrations of ","suffix":" in 10 healthy volunteers (mean±s.e. mean) after a 40 mg ora","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"33","endOffset":"44","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[2]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[2]/div[1]/div[2]/span[1]","prefix":"The pharmacokinetic variables of ","suffix":" 40 mg (mean±s.d. or median and range) in 10 subjects (study","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"107","endOffset":"118","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","prefix":"and its active metabolite hydroxyitraconazole on the day of ","suffix":" or lovastatin administration are shown in ","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"53","endOffset":"64","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","prefix":"Plasma concentrations of itraconazole (open circles, ","suffix":" study; closed circles, lovastatin study) and hydroxyitracon","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"314","endOffset":"325","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"lasma fluvastatin concentrations. However, the half-life of ","suffix":" was slightly prolonged by itraconazole, but this should not","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"98","endOffset":"109","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"th the knowledge of the biotransformation of lovastatin and ","suffix":". The pro-drug lovastatin is partly hydrolysed to the active","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"155","endOffset":"166","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"acid concentrations as well as its lack of effect on plasma ","suffix":", it is unlikely that a clinically significant interaction w","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"327","endOffset":"338","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":" dosages of itraconazole. In a recent study, AUC values for ","suffix":" were about 2-fold higher in hypercholesterolaemic renal tra","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"65","endOffset":"76","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[11]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[11]/span[1]","prefix":"on H, Eriksson B-M. Liquid chromatographic determination of ","suffix":" and its enantiomers in blood plasma by automated solid-phas","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"34","endOffset":"45","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[14]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[14]/span[1]","prefix":"Goldberg R, Roth D. Evaluation of ","suffix":" in the treatment of hypercholesterolemia in renal transplan","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"25","endOffset":"36","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[1]/div[1]/div[2]/span[1]","prefix":"Plasma concentrations of ","suffix":" in 10 healthy volunteers (mean±s.e. mean) after a 40 mg ora","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"33","endOffset":"44","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[2]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[2]/div[1]/div[2]/span[1]","prefix":"The pharmacokinetic variables of ","suffix":" 40 mg (mean±s.d. or median and range) in 10 subjects (study","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"107","endOffset":"118","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","prefix":"and its active metabolite hydroxyitraconazole on the day of ","suffix":" or lovastatin administration are shown in ","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"53","endOffset":"64","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","prefix":"Plasma concentrations of itraconazole (open circles, ","suffix":" study; closed circles, lovastatin study) and hydroxyitracon","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"147","endOffset":"158","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","prefix":" lovastatin study) and hydroxyitraconazole (open triangles, ","suffix":" study; closed triangles, lovastatin study) after intake of ","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"260","endOffset":"271","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":" contrast, itraconazole had no significant effect on plasma ","suffix":" concentrations. However, the half-life of fluvastatin was s","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"314","endOffset":"325","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"lasma fluvastatin concentrations. However, the half-life of ","suffix":" was slightly prolonged by itraconazole, but this should not","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"98","endOffset":"109","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"th the knowledge of the biotransformation of lovastatin and ","suffix":". The pro-drug lovastatin is partly hydrolysed to the active","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"155","endOffset":"166","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"acid concentrations as well as its lack of effect on plasma ","suffix":", it is unlikely that a clinically significant interaction w","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"245","endOffset":"256","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"at a clinically significant interaction would occur between ","suffix":" and higher dosages of itraconazole. In a recent study, AUC ","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"327","endOffset":"338","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":" dosages of itraconazole. In a recent study, AUC values for ","suffix":" were about 2-fold higher in hypercholesterolaemic renal tra","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"425","endOffset":"436","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"n hypercholesterolaemic renal transplant patients receiving ","suffix":" 20 mg day","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"394","endOffset":"405","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"greatly reduced while using CYP3A4 inhibitors. By contrast, ","suffix":" concentrations were not significantly increased by itracona","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"451","endOffset":"462","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"ot significantly increased by itraconazole, indicating that ","suffix":" has much less potential than lovastatin for clinically sign","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"487","endOffset":"498","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"ot significantly increased by itraconazole, indicating that ","suffix":" has much less potential than lovastatin for clinically sign","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"fluvastatin","startOffset":"155","endOffset":"166","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/p[1]","prefix":"n and Mrs Eija Mäkinen-Pulli is greatly appreciated. Plasma ","suffix":" concentrations were kindly determined by Astra Hässle Ltd. ","exact":"fluvastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"77","endOffset":"87","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":" of itraconazole on the pharmacokinetics of fluvastatin and ","suffix":"","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"71","endOffset":"81","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":" of itraconazole on the pharmacokinetics of fluvastatin and ","suffix":", two inhibitors of HMG-CoA reductase with different pharmac","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"302","endOffset":"312","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"once daily for 4 days. On day 4, 40 mg fluvastatin or 40 mg ","suffix":" was administered orally. Plasma concentrations of fluvastat","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"376","endOffset":"386","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" administered orally. Plasma concentrations of fluvastatin, ","suffix":", lovastatin acid, itraconazole and hydroxyitraconazole were","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"388","endOffset":"398","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"d orally. Plasma concentrations of fluvastatin, lovastatin, ","suffix":" acid, itraconazole and hydroxyitraconazole were determined ","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"96","endOffset":"106","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" of 100 mg daily, greatly elevated plasma concentrations of ","suffix":" and its active metabolite, lovastatin acid. Lovastatin shou","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"134","endOffset":"144","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"sma concentrations of lovastatin and its active metabolite, ","suffix":" acid. Lovastatin should therefore not be used concomitantly","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"151","endOffset":"161","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"s of lovastatin and its active metabolite, lovastatin acid. ","suffix":" should therefore not be used concomitantly with itraconazol","exact":"Lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"276","endOffset":"286","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"nazole and other potent CYP3A4 inhibitors, or the dosage of ","suffix":" should be greatly reduced while using a CYP3A4 inhibitor. I","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"492","endOffset":"502","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"e, indicating that fluvastatin has much less potential than ","suffix":" for clinically significant interactions with itraconazole a","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"528","endOffset":"538","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"e, indicating that fluvastatin has much less potential than ","suffix":" for clinically significant interactions with itraconazole a","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"40","endOffset":"50","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"fluvastatin, interaction, itraconazole, ","suffix":", pharmacokinetics","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"16","endOffset":"26","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","prefix":"Fluvastatin and ","suffix":" are inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HM","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"218","endOffset":"228","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","prefix":" are widely used in the treatment of hypercholesterolaemia. ","suffix":" is an inactive lactone pro-drug which is hydrolysed ","exact":"Lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"19","endOffset":"29","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[2]","prefix":"Concomitant use of ","suffix":" and, for example, cyclosporine, erythromycin or itraconazol","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"149","endOffset":"159","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":"e range, 20–25 years; weight range, 54–85 kg) and 10 in the ","suffix":" study (two women and eight men; age range, 19–24 years; wei","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"655","endOffset":"665","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":"e females who were using oral contraceptive steroids in the ","suffix":" and fluvastatin studies, respectively.","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"302","endOffset":"312","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"once daily for 4 days. On day 4, 40 mg fluvastatin or 40 mg ","suffix":" was administered orally. Plasma concentrations of fluvastat","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"436","endOffset":"446","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ef 40 mg capsule, Astra Ltd, Kirkkonummi, Finland) or 40 mg ","suffix":" (one Mevacor 40 mg tablet, Merck Sharp & Dohme B.V., Haarle","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"690","endOffset":"700","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ects fasted for 1 h before administration of fluvastatin or ","suffix":". A warm standard meal was served 4 h and a light standard m","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"789","endOffset":"799","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"rved 4 h and a light standard meal 8 h after fluvastatin or ","suffix":" intake. The subjects were not allowed to drink grapefruit j","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"102","endOffset":"112","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"d timed blood samples were drawn just before fluvastatin or ","suffix":" was administered and 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 h lat","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"354","endOffset":"364","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"s stored at −40° C until analysis. Plasma concentrations of ","suffix":" and lovastatin acid were determined by high performance liq","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"369","endOffset":"379","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"° C until analysis. Plasma concentrations of lovastatin and ","suffix":" acid were determined by high performance liquid chromatogra","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"94","endOffset":"104","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"sma itraconazole and hydroxyitraconazole levels between the ","suffix":" and fluvastatin studies, plasma itraconazole and hydroxyitr","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"37","endOffset":"47","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"The pharmacokinetics of fluvastatin, ","suffix":" and lovastatin acid were characterized, as appropriate, by ","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"52","endOffset":"62","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"The pharmacokinetics of fluvastatin, lovastatin and ","suffix":" acid were characterized, as appropriate, by peak concentrat","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"121","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[2]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/div[2]/div[1]/div[2]/span[1]","prefix":" or median and range) in 10 subjects (study I) and those of ","suffix":" 40 mg in 10 subjects (study II), following pretreatment wit","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"70","endOffset":"80","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","prefix":"le considerably increased the plasma concentrations of both ","suffix":" and lovastatin acid, compared with placebo (","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"85","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","prefix":" increased the plasma concentrations of both lovastatin and ","suffix":" acid, compared with placebo (","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"25","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Plasma concentrations of ","suffix":" (a) and lovastatin acid (b) in 10 healthy volunteers (mean±","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"77","endOffset":"87","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":" of itraconazole on the pharmacokinetics of fluvastatin and ","suffix":"","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"369","endOffset":"379","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"° C until analysis. Plasma concentrations of lovastatin and ","suffix":" acid were determined by high performance liquid chromatogra","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"52","endOffset":"62","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"The pharmacokinetics of fluvastatin, lovastatin and ","suffix":" acid were characterized, as appropriate, by peak concentrat","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"44","endOffset":"54","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Plasma concentrations of lovastatin (a) and ","suffix":" acid (b) in 10 healthy volunteers (mean±s.e. mean) after a ","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"111","endOffset":"121","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","prefix":"conazole, 200 mg daily, increased the AUC of lovastatin and ","suffix":" acid about 20-fold [","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"84","endOffset":"94","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"ffect of itraconazole 100 mg daily on plasma lovastatin and ","suffix":" acid concentrations as well as its lack of effect on plasma","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"133","endOffset":"143","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"lthy volunteers (mean±s.e. mean) after a 40 mg oral dose of ","suffix":", following pretreatment with 100 mg itraconazole (closed ci","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"122","endOffset":"132","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","prefix":"metabolite hydroxyitraconazole on the day of fluvastatin or ","suffix":" administration are shown in ","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"88","endOffset":"98","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","prefix":"aconazole (open circles, fluvastatin study; closed circles, ","suffix":" study) and hydroxyitraconazole (open triangles, fluvastatin","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"184","endOffset":"194","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","prefix":"azole (open triangles, fluvastatin study; closed triangles, ","suffix":" study) after intake of 100 mg itraconazole orally once dail","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"81","endOffset":"91","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"tudy demonstrate that plasma concentrations of the pro-drug ","suffix":" and its active metabolite, lovastatin acid, are greatly inc","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"119","endOffset":"129","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"tions of the pro-drug lovastatin and its active metabolite, ","suffix":" acid, are greatly increased by a daily dose of 100 mg itrac","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"448","endOffset":"458","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"ve any clinical relevance. The increase in the total AUC of ","suffix":" acid by itraconazole was, on an average, 15-fold, but showe","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"621","endOffset":"631","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"azole appeared to have a similar effect on the total AUC of ","suffix":"; however, this interaction could not be accurately quantifi","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"705","endOffset":"715","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"s interaction could not be accurately quantified, since the ","suffix":" concentrations during the placebo phase were often below th","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"83","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"od agreement with the knowledge of the biotransformation of ","suffix":" and fluvastatin. The pro-drug lovastatin is partly hydrolys","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"124","endOffset":"134","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"otransformation of lovastatin and fluvastatin. The pro-drug ","suffix":" is partly hydrolysed to the active metabolite, lovastatin a","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"182","endOffset":"192","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"g lovastatin is partly hydrolysed to the active metabolite, ","suffix":" acid; this metabolic pathway is not dependent on the CYP en","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"316","endOffset":"326","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"s. In contrast, formation of the other major metabolites of ","suffix":" is catalysed by CYP enzymes, primarily by CYP3A4 [","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"0","endOffset":"10","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"","suffix":" has a low oral bioavailability due to incomplete absorption","exact":"Lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"96","endOffset":"106","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","prefix":"tment with itraconazole, 200 mg daily, increased the AUC of ","suffix":" and lovastatin acid about 20-fold [","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"111","endOffset":"121","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[4]","prefix":"conazole, 200 mg daily, increased the AUC of lovastatin and ","suffix":" acid about 20-fold [","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"69","endOffset":"79","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"ng the marked effect of itraconazole 100 mg daily on plasma ","suffix":" and lovastatin acid concentrations as well as its lack of e","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"84","endOffset":"94","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[5]","prefix":"ffect of itraconazole 100 mg daily on plasma lovastatin and ","suffix":" acid concentrations as well as its lack of effect on plasma","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"171","endOffset":"181","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[6]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[6]","prefix":"e incidence and severity of the skeletal muscle toxicity of ","suffix":" [","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"77","endOffset":"87","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":" of itraconazole on the pharmacokinetics of fluvastatin and ","suffix":"","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"171","endOffset":"181","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[6]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[6]","prefix":"e incidence and severity of the skeletal muscle toxicity of ","suffix":" [","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"60","endOffset":"70","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[6]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[6]/span[1]","prefix":"Tobert JA. Efficacy and long-term adverse effect pattern of ","suffix":". ","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"72","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[7]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[7]","prefix":"formation of the pro-drug simvastatin is similar to that of ","suffix":" [","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"145","endOffset":"155","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":" of 100 mg daily, greatly elevates plasma concentrations of ","suffix":" and its active metabolite, lovastatin acid. Lovastatin (and","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"134","endOffset":"144","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"sma concentrations of lovastatin and its active metabolite, ","suffix":" acid. Lovastatin should therefore not be used concomitantly","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"183","endOffset":"193","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"sma concentrations of lovastatin and its active metabolite, ","suffix":" acid. Lovastatin (and simvastatin) should not be used conco","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"151","endOffset":"161","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"s of lovastatin and its active metabolite, lovastatin acid. ","suffix":" should therefore not be used concomitantly with itraconazol","exact":"Lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"0","endOffset":"10","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"","suffix":" has a low oral bioavailability due to incomplete absorption","exact":"Lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"200","endOffset":"210","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"s of lovastatin and its active metabolite, lovastatin acid. ","suffix":" (and simvastatin) should not be used concomitantly with pot","exact":"Lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"492","endOffset":"502","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"e, indicating that fluvastatin has much less potential than ","suffix":" for clinically significant interactions with itraconazole a","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"lovastatin","startOffset":"528","endOffset":"538","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"e, indicating that fluvastatin has much less potential than ","suffix":" for clinically significant interactions with itraconazole a","exact":"lovastatin"},{"setid":"PMC1873980","drugname":"mevacor","startOffset":"452","endOffset":"459","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":", Astra Ltd, Kirkkonummi, Finland) or 40 mg lovastatin (one ","suffix":" 40 mg tablet, Merck Sharp & Dohme B.V., Haarlem, Netherland","exact":"Mevacor"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"422","endOffset":"441","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" fluvastatin, lovastatin, lovastatin acid, itraconazole and ","suffix":" were determined up to 24 h.","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"55","endOffset":"74","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"To assess the comparability of plasma itraconazole and ","suffix":" levels between the lovastatin and fluvastatin studies, plas","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"154","endOffset":"173","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"lovastatin and fluvastatin studies, plasma itraconazole and ","suffix":" concentrations were determined in all samples, i.e. from 1 ","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"306","endOffset":"325","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"ast itraconazole dose on day 4 up to 25 h. Itraconazole and ","suffix":" concentrations were determined by h.p.l.c. as previously de","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"73","endOffset":"92","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","prefix":"ma concentrations of itraconazole and its active metabolite ","suffix":" on the day of fluvastatin or lovastatin administration are ","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"422","endOffset":"441","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" fluvastatin, lovastatin, lovastatin acid, itraconazole and ","suffix":" were determined up to 24 h.","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"55","endOffset":"74","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"To assess the comparability of plasma itraconazole and ","suffix":" levels between the lovastatin and fluvastatin studies, plas","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"154","endOffset":"173","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"lovastatin and fluvastatin studies, plasma itraconazole and ","suffix":" concentrations were determined in all samples, i.e. from 1 ","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"306","endOffset":"325","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[3]","prefix":"ast itraconazole dose on day 4 up to 25 h. Itraconazole and ","suffix":" concentrations were determined by h.p.l.c. as previously de","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"73","endOffset":"92","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/p[1]","prefix":"ma concentrations of itraconazole and its active metabolite ","suffix":" on the day of fluvastatin or lovastatin administration are ","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"hydroxyitraconazole","startOffset":"110","endOffset":"129","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[3]/div[1]/div[1]/div[2]/span[1]","prefix":"s, fluvastatin study; closed circles, lovastatin study) and ","suffix":" (open triangles, fluvastatin study; closed triangles, lovas","exact":"hydroxyitraconazole"},{"setid":"PMC1873980","drugname":"cholesterol","startOffset":"130","endOffset":"141","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","prefix":"l-coenzyme A (HMG-CoA) reductase, the rate-limiting step in ","suffix":" synthesis, which are widely used in the treatment of hyperc","exact":"cholesterol"},{"setid":"PMC1873980","drugname":"cyclosporine","startOffset":"48","endOffset":"60","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[2]","prefix":"Concomitant use of lovastatin and, for example, ","suffix":", erythromycin or itraconazole is associated with a consider","exact":"cyclosporine"},{"setid":"PMC1873980","drugname":"cyclosporine","startOffset":"52","endOffset":"64","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[6]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[6]","prefix":"Concomitant administration of the CYP3A4 inhibitors ","suffix":" and erythromycin has been shown to increase the incidence a","exact":"cyclosporine"},{"setid":"PMC1873980","drugname":"erythromycin","startOffset":"62","endOffset":"74","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[2]","prefix":"ncomitant use of lovastatin and, for example, cyclosporine, ","suffix":" or itraconazole is associated with a considerably increased","exact":"erythromycin"},{"setid":"PMC1873980","drugname":"erythromycin","startOffset":"69","endOffset":"81","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[6]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[6]","prefix":"nt administration of the CYP3A4 inhibitors cyclosporine and ","suffix":" has been shown to increase the incidence and severity of th","exact":"erythromycin"},{"setid":"PMC1873980","drugname":"creatinine","startOffset":"452","endOffset":"462","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":" tests (including blood haemoglobin, serum creatine kinase, ","suffix":" and alanine aminotransferase) before entering the study. No","exact":"creatinine"},{"setid":"PMC1873980","drugname":"alanine","startOffset":"467","endOffset":"474","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[1]/p[1]","prefix":"ng blood haemoglobin, serum creatine kinase, creatinine and ","suffix":" aminotransferase) before entering the study. None of them h","exact":"alanine"},{"setid":"PMC1873980","drugname":"edta","startOffset":"278","endOffset":"282","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"into tubes that contained ethylenediaminetetra-acetic acid (","suffix":"). Plasma was stored at −40° C until analysis. Plasma concen","exact":"EDTA"},{"setid":"PMC1873980","drugname":"simvastatin","startOffset":"38","endOffset":"49","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[7]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[7]","prefix":"The biotransformation of the pro-drug ","suffix":" is similar to that of lovastatin [","exact":"simvastatin"},{"setid":"PMC1873980","drugname":"simvastatin","startOffset":"216","endOffset":"227","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[8]","prefix":"and its active metabolite, lovastatin acid. Lovastatin (and ","suffix":") should not be used concomitantly with potent CYP3A4 inhibi","exact":"simvastatin"},{"setid":"PMC1873980","drugname":"simvastatin","startOffset":"94","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[20]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[9]/div[1]/div[20]/span[1]","prefix":"ositis and rhabdomyolysis associated with concurrent use of ","suffix":" and nefazodone. ","exact":"simvastatin"}],[{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"253","endOffset":"263","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" another occasion ziprasidone was co-administered with oral ","suffix":" 800 mg and on a third occasion ziprasidone was co-administe","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"22","endOffset":"32","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"The administration of ","suffix":" increased the ziprasidone AUC(0, ∞) by 6% but there were no","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","prefix":"ial inhibition of individual human liver cytochrome P450 by ","suffix":". ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"85","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"iprasidone are not affected by concurrent administration of ","suffix":" or Maalox®. This suggests that other nonspecific inhibitors","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"24","endOffset":"34","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"ziprasidone, aluminium, ","suffix":", interaction, magnesium, pharmacokinetics","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"66","endOffset":"76","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","prefix":"tudy was designed to determine whether or not multiple-dose ","suffix":" or antacid administration alters the pharmacokinetics of zi","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"sover study designed to determine whether multiple doses of ","suffix":" and Maalox® alter the pharmacokinetics of ziprasidone. The ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"325","endOffset":"335","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"eatments were: ziprasidone 40 mg alone; ziprasidone 40 mg + ","suffix":" 800 mg; and ziprasidone 40 mg + Maalox® 30 ml (aluminium hy","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"114","endOffset":"124","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"rally, after a standard breakfast at approximately 09.00 h. ","suffix":" tablets were administered once daily, at approximately 07.0","exact":"Cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"243","endOffset":"253","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"fter completing the ziprasidone + Maalox® and ziprasidone + ","suffix":" treatment periods.","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","prefix":"ial inhibition of individual human liver cytochrome P450 by ","suffix":". ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"71","endOffset":"81","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":"okinetics of ziprasidone in healthy volunteers treated with ","suffix":" or antacid","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"27","endOffset":"37","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of ","suffix":" and Maalox® (aluminium hydroxide 1.35 g and magnesium hydro","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"253","endOffset":"263","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" another occasion ziprasidone was co-administered with oral ","suffix":" 800 mg and on a third occasion ziprasidone was co-administe","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"22","endOffset":"32","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"The administration of ","suffix":" increased the ziprasidone AUC(0, ∞) by 6% but there were no","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"85","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"iprasidone are not affected by concurrent administration of ","suffix":" or Maalox®. This suggests that other nonspecific inhibitors","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"24","endOffset":"34","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"ziprasidone, aluminium, ","suffix":", interaction, magnesium, pharmacokinetics","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"66","endOffset":"76","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","prefix":"tudy was designed to determine whether or not multiple-dose ","suffix":" or antacid administration alters the pharmacokinetics of zi","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"sover study designed to determine whether multiple doses of ","suffix":" and Maalox® alter the pharmacokinetics of ziprasidone. The ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"325","endOffset":"335","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"eatments were: ziprasidone 40 mg alone; ziprasidone 40 mg + ","suffix":" 800 mg; and ziprasidone 40 mg + Maalox® 30 ml (aluminium hy","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"243","endOffset":"253","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"fter completing the ziprasidone + Maalox® and ziprasidone + ","suffix":" treatment periods.","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"111","endOffset":"121","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"group (ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone + ","suffix":" ▴).","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"100","endOffset":"110","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"group (ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone + ","suffix":" ▴). Group means are shown as horizontal dashed lines.","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"69","endOffset":"79","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"from this study indicate that concomitant administration of ","suffix":" produces a small increase in systemic exposure to ziprasido","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"447","endOffset":"457","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"linically significant differences between the ziprasidone + ","suffix":" and ziprasidone alone groups. Similarly, no statistically s","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"46","endOffset":"56","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"The lack of clinically significant effects of ","suffix":" on the pharmacokinetics of ziprasidone was observed despite","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"96","endOffset":"106","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"study indicate that the administration of multiple doses of ","suffix":" or of Maalox® do not exert any clinically significant influ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","prefix":"ial inhibition of individual human liver cytochrome P450 by ","suffix":". ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","prefix":"ial inhibition of individual human liver cytochrome P450 by ","suffix":". ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"71","endOffset":"81","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":"okinetics of ziprasidone in healthy volunteers treated with ","suffix":" or antacid","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"27","endOffset":"37","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of ","suffix":" and Maalox® (aluminium hydroxide 1.35 g and magnesium hydro","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"253","endOffset":"263","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" another occasion ziprasidone was co-administered with oral ","suffix":" 800 mg and on a third occasion ziprasidone was co-administe","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"22","endOffset":"32","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"The administration of ","suffix":" increased the ziprasidone AUC(0, ∞) by 6% but there were no","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"85","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"iprasidone are not affected by concurrent administration of ","suffix":" or Maalox®. This suggests that other nonspecific inhibitors","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"24","endOffset":"34","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"ziprasidone, aluminium, ","suffix":", interaction, magnesium, pharmacokinetics","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"66","endOffset":"76","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","prefix":"tudy was designed to determine whether or not multiple-dose ","suffix":" or antacid administration alters the pharmacokinetics of zi","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"sover study designed to determine whether multiple doses of ","suffix":" and Maalox® alter the pharmacokinetics of ziprasidone. The ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"325","endOffset":"335","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"eatments were: ziprasidone 40 mg alone; ziprasidone 40 mg + ","suffix":" 800 mg; and ziprasidone 40 mg + Maalox® 30 ml (aluminium hy","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"243","endOffset":"253","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"fter completing the ziprasidone + Maalox® and ziprasidone + ","suffix":" treatment periods.","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"111","endOffset":"121","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"group (ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone + ","suffix":" ▴).","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"100","endOffset":"110","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"group (ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone + ","suffix":" ▴). Group means are shown as horizontal dashed lines.","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"69","endOffset":"79","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"from this study indicate that concomitant administration of ","suffix":" produces a small increase in systemic exposure to ziprasido","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"447","endOffset":"457","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"linically significant differences between the ziprasidone + ","suffix":" and ziprasidone alone groups. Similarly, no statistically s","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"46","endOffset":"56","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"The lack of clinically significant effects of ","suffix":" on the pharmacokinetics of ziprasidone was observed despite","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"96","endOffset":"106","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"study indicate that the administration of multiple doses of ","suffix":" or of Maalox® do not exert any clinically significant influ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","prefix":"ial inhibition of individual human liver cytochrome P450 by ","suffix":". ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"71","endOffset":"81","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":"okinetics of ziprasidone in healthy volunteers treated with ","suffix":" or antacid","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"27","endOffset":"37","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of ","suffix":" and Maalox® (aluminium hydroxide 1.35 g and magnesium hydro","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"253","endOffset":"263","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" another occasion ziprasidone was co-administered with oral ","suffix":" 800 mg and on a third occasion ziprasidone was co-administe","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"22","endOffset":"32","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"The administration of ","suffix":" increased the ziprasidone AUC(0, ∞) by 6% but there were no","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"85","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"iprasidone are not affected by concurrent administration of ","suffix":" or Maalox®. This suggests that other nonspecific inhibitors","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"24","endOffset":"34","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"ziprasidone, aluminium, ","suffix":", interaction, magnesium, pharmacokinetics","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"66","endOffset":"76","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","prefix":"tudy was designed to determine whether or not multiple-dose ","suffix":" or antacid administration alters the pharmacokinetics of zi","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"sover study designed to determine whether multiple doses of ","suffix":" and Maalox® alter the pharmacokinetics of ziprasidone. The ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"325","endOffset":"335","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"eatments were: ziprasidone 40 mg alone; ziprasidone 40 mg + ","suffix":" 800 mg; and ziprasidone 40 mg + Maalox® 30 ml (aluminium hy","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"243","endOffset":"253","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"fter completing the ziprasidone + Maalox® and ziprasidone + ","suffix":" treatment periods.","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"111","endOffset":"121","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"group (ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone + ","suffix":" ▴).","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"100","endOffset":"110","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"group (ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone + ","suffix":" ▴). Group means are shown as horizontal dashed lines.","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"69","endOffset":"79","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"from this study indicate that concomitant administration of ","suffix":" produces a small increase in systemic exposure to ziprasido","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"447","endOffset":"457","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"linically significant differences between the ziprasidone + ","suffix":" and ziprasidone alone groups. Similarly, no statistically s","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"46","endOffset":"56","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"The lack of clinically significant effects of ","suffix":" on the pharmacokinetics of ziprasidone was observed despite","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"96","endOffset":"106","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"study indicate that the administration of multiple doses of ","suffix":" or of Maalox® do not exert any clinically significant influ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","prefix":"ial inhibition of individual human liver cytochrome P450 by ","suffix":". ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"69","endOffset":"79","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"from this study indicate that concomitant administration of ","suffix":" produces a small increase in systemic exposure to ziprasido","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"447","endOffset":"457","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"linically significant differences between the ziprasidone + ","suffix":" and ziprasidone alone groups. Similarly, no statistically s","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"110","endOffset":"120","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[4]/span[1]","prefix":"ial inhibition of individual human liver cytochrome P450 by ","suffix":". ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"46","endOffset":"56","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"The lack of clinically significant effects of ","suffix":" on the pharmacokinetics of ziprasidone was observed despite","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"cimetidine","startOffset":"96","endOffset":"106","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"study indicate that the administration of multiple doses of ","suffix":" or of Maalox® do not exert any clinically significant influ","exact":"cimetidine"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"42","endOffset":"48","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"To evaluate the effects of cimetidine and ","suffix":"® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g)","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"337","endOffset":"343","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":" a third occasion ziprasidone was co-administered with oral ","suffix":"®.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"99","endOffset":"105","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" not affected by concurrent administration of cimetidine or ","suffix":"®. This suggests that other nonspecific inhibitors of cytoch","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"125","endOffset":"131","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"igned to determine whether multiple doses of cimetidine and ","suffix":"® alter the pharmacokinetics of ziprasidone. The study proto","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"368","endOffset":"374","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"rasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + ","suffix":"® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"293","endOffset":"299","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ration and continuing until 1 day after ziprasidone dosing. ","suffix":"® suspension was administered on the evening before the admi","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"217","endOffset":"223","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"udy for personal reasons after completing the ziprasidone + ","suffix":"® and ziprasidone + cimetidine treatment periods.","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"87","endOffset":"93","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"entrations by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴).","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"76","endOffset":"82","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":",∞) values by treatment group (ziprasidone ◊; ziprasidone + ","suffix":"®▪; ziprasidone + cimetidine ▴). Group means are shown as ho","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"566","endOffset":"572","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically significant differences between the ziprasidone + ","suffix":"® and ziprasidone alone groups were observed for any of the ","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"maalox","startOffset":"113","endOffset":"119","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"at the administration of multiple doses of cimetidine or of ","suffix":"® do not exert any clinically significant influence on the s","exact":"Maalox"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"136","endOffset":"147","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[1]/p[1]","prefix":"g and magnesium hydroxide 1.2 g) on the pharmacokinetics of ","suffix":".","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"79","endOffset":"90","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"g subjects aged 18–45 years were given single oral doses of ","suffix":" 40 mg on three occasions at least 7 days apart. On one occa","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"155","endOffset":"166","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"g on three occasions at least 7 days apart. On one occasion ","suffix":" was administered alone, on another occasion ziprasidone was","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"211","endOffset":"222","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"ion ziprasidone was administered alone, on another occasion ","suffix":" was co-administered with oral cimetidine 800 mg and on a th","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"295","endOffset":"306","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"istered with oral cimetidine 800 mg and on a third occasion ","suffix":" was co-administered with oral Maalox®.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"47","endOffset":"58","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"The administration of cimetidine increased the ","suffix":" AUC(0, ∞) by 6% but there were no statistically significant","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"The pharmacokinetics of ","suffix":" are not affected by concurrent administration of cimetidine","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"234","endOffset":"245","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" and antacids are unlikely to alter the pharmacokinetics of ","suffix":".","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[1]","prefix":"","suffix":" has a pharmacokinetic profile unaffected by age and gender ","exact":"Ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"134","endOffset":"145","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[4]/p[4]","prefix":"ne or antacid administration alters the pharmacokinetics of ","suffix":".","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"234","endOffset":"245","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":" and antacids are unlikely to alter the pharmacokinetics of ","suffix":".","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"163","endOffset":"174","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ses of cimetidine and Maalox® alter the pharmacokinetics of ","suffix":". The study protocol was approved by an independent institut","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"280","endOffset":"291","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"puter-generated randomization. These three treatments were: ","suffix":" 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and zip","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone hydrochloride","startOffset":"0","endOffset":"25","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"","suffix":" capsules were administered orally, after a standard breakfa","exact":"Ziprasidone hydrochloride"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"213","endOffset":"224","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ce daily, at approximately 07.00h, commencing 2 days before ","suffix":" administration and continuing until 1 day after ziprasidone","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"273","endOffset":"284","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone administration and continuing until 1 day after ","suffix":" dosing. Maalox® suspension was administered on the evening ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"373","endOffset":"384","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"as administered on the evening before the administration of ","suffix":" (approximately 23.00 h), immediately before the ziprasidone","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"433","endOffset":"444","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone (approximately 23.00 h), immediately before the ","suffix":" dosing (approximately 09.00 h), and after lunch (approximat","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"568","endOffset":"579","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"13.00 h) and dinner (approximately 18.00 h) on the day that ","suffix":" was taken.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"45","endOffset":"56","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"Blood samples for the determination of serum ","suffix":" concentrations were collected immediately before dosing and","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"166","endOffset":"177","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"dosing and at fixed intervals up to 36 h after each dose of ","suffix":".","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"Serum concentrations of ","suffix":" were determined using high performance liquid chromatograph","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"35","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","prefix":"The maximum serum concentration of ","suffix":" (","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"92","endOffset":"103","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"dy after experiencing adverse events and only completed the ","suffix":" treatment period. Another subject discontinued the study fo","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"203","endOffset":"214","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"ntinued the study for personal reasons after completing the ","suffix":" + Maalox® and ziprasidone + cimetidine treatment periods.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"295","endOffset":"306","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"istered with oral cimetidine 800 mg and on a third occasion ","suffix":" was co-administered with oral Maalox®.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"163","endOffset":"174","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ses of cimetidine and Maalox® alter the pharmacokinetics of ","suffix":". The study protocol was approved by an independent institut","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"273","endOffset":"284","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone administration and continuing until 1 day after ","suffix":" dosing. Maalox® suspension was administered on the evening ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"568","endOffset":"579","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"13.00 h) and dinner (approximately 18.00 h) on the day that ","suffix":" was taken.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"92","endOffset":"103","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"dy after experiencing adverse events and only completed the ","suffix":" treatment period. Another subject discontinued the study fo","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"229","endOffset":"240","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"onal reasons after completing the ziprasidone + Maalox® and ","suffix":" + cimetidine treatment periods.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"462","endOffset":"473","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"ficant differences between the ziprasidone + cimetidine and ","suffix":" alone groups. Similarly, no statistically significant diffe","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"578","endOffset":"589","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"gnificant differences between the ziprasidone + Maalox® and ","suffix":" alone groups were observed for any of the measured pharmaco","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"87","endOffset":"98","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[1]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[1]/span[1]","prefix":"ris B, et al. Single- and multiple-dose pharmacokinetics of ","suffix":" in healthy young and elderly volunteers. ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"15","endOffset":"26","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","prefix":"The mean serum ","suffix":" concentration–time curves for the three treatment groups we","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"11","endOffset":"22","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Mean serum ","suffix":" concentrations by treatment group (ziprasidone ◊; ziprasido","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":"The pharmacokinetics of ","suffix":" in healthy volunteers treated with cimetidine or antacid","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"79","endOffset":"90","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"g subjects aged 18–45 years were given single oral doses of ","suffix":" 40 mg on three occasions at least 7 days apart. On one occa","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"155","endOffset":"166","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"g on three occasions at least 7 days apart. On one occasion ","suffix":" was administered alone, on another occasion ziprasidone was","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"211","endOffset":"222","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"ion ziprasidone was administered alone, on another occasion ","suffix":" was co-administered with oral cimetidine 800 mg and on a th","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"295","endOffset":"306","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"istered with oral cimetidine 800 mg and on a third occasion ","suffix":" was co-administered with oral Maalox®.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"47","endOffset":"58","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"The administration of cimetidine increased the ","suffix":" AUC(0, ∞) by 6% but there were no statistically significant","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"The pharmacokinetics of ","suffix":" are not affected by concurrent administration of cimetidine","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"163","endOffset":"174","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ses of cimetidine and Maalox® alter the pharmacokinetics of ","suffix":". The study protocol was approved by an independent institut","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"280","endOffset":"291","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"puter-generated randomization. These three treatments were: ","suffix":" 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and zip","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"213","endOffset":"224","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ce daily, at approximately 07.00h, commencing 2 days before ","suffix":" administration and continuing until 1 day after ziprasidone","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"273","endOffset":"284","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone administration and continuing until 1 day after ","suffix":" dosing. Maalox® suspension was administered on the evening ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"373","endOffset":"384","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"as administered on the evening before the administration of ","suffix":" (approximately 23.00 h), immediately before the ziprasidone","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"433","endOffset":"444","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone (approximately 23.00 h), immediately before the ","suffix":" dosing (approximately 09.00 h), and after lunch (approximat","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"568","endOffset":"579","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"13.00 h) and dinner (approximately 18.00 h) on the day that ","suffix":" was taken.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"45","endOffset":"56","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"Blood samples for the determination of serum ","suffix":" concentrations were collected immediately before dosing and","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"Serum concentrations of ","suffix":" were determined using high performance liquid chromatograph","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"35","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","prefix":"The maximum serum concentration of ","suffix":" (","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"92","endOffset":"103","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"dy after experiencing adverse events and only completed the ","suffix":" treatment period. Another subject discontinued the study fo","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"203","endOffset":"214","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"ntinued the study for personal reasons after completing the ","suffix":" + Maalox® and ziprasidone + cimetidine treatment periods.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"229","endOffset":"240","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"onal reasons after completing the ziprasidone + Maalox® and ","suffix":" + cimetidine treatment periods.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"15","endOffset":"26","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","prefix":"The mean serum ","suffix":" concentration–time curves for the three treatment groups we","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"11","endOffset":"22","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Mean serum ","suffix":" concentrations by treatment group (ziprasidone ◊; ziprasido","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"58","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Mean serum ziprasidone concentrations by treatment group (","suffix":" ◊; ziprasidone + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"35","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[2]","prefix":"The pharmacokinetic parameters for ","suffix":" across the three treatment groups were generally similar (","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"47","endOffset":"58","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"Individual AUC(0,∞) values by treatment group (","suffix":" ◊; ziprasidone + Maalox®▪; ziprasidone + cimetidine ▴). Gro","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"130","endOffset":"141","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"imetidine produces a small increase in systemic exposure to ","suffix":" as measured by the AUC(0,∞). Although this increase was sta","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"433","endOffset":"444","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically or clinically significant differences between the ","suffix":" + cimetidine and ziprasidone alone groups. Similarly, no st","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"462","endOffset":"473","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"ficant differences between the ziprasidone + cimetidine and ","suffix":" alone groups. Similarly, no statistically significant diffe","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"552","endOffset":"563","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"larly, no statistically significant differences between the ","suffix":" + Maalox® and ziprasidone alone groups were observed for an","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"578","endOffset":"589","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"gnificant differences between the ziprasidone + Maalox® and ","suffix":" alone groups were observed for any of the measured pharmaco","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"84","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"ignificant effects of cimetidine on the pharmacokinetics of ","suffix":" was observed despite the fact that oxidative ziprasidone me","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"141","endOffset":"152","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"of ziprasidone was observed despite the fact that oxidative ","suffix":" metabolism is primarily mediated by CYP3A4 [","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"210","endOffset":"221","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"ignificant influence on the single-dose pharmacokinetics of ","suffix":" 40 mg.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"87","endOffset":"98","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[1]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[1]/span[1]","prefix":"ris B, et al. Single- and multiple-dose pharmacokinetics of ","suffix":" in healthy young and elderly volunteers. ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"141","endOffset":"152","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[2]/span[1]","prefix":"ome P450 isoform responsible for the primary metabolites of ","suffix":" and prediction of possible drug interactions. ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"35","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[2]","prefix":"The pharmacokinetic parameters for ","suffix":" across the three treatment groups were generally similar (","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"41","endOffset":"52","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[2]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[2]/div[1]/div[2]/span[1]","prefix":"Summary of pharmacokinetic parameters of ","suffix":".","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":"The pharmacokinetics of ","suffix":" in healthy volunteers treated with cimetidine or antacid","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"79","endOffset":"90","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"g subjects aged 18–45 years were given single oral doses of ","suffix":" 40 mg on three occasions at least 7 days apart. On one occa","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"155","endOffset":"166","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"g on three occasions at least 7 days apart. On one occasion ","suffix":" was administered alone, on another occasion ziprasidone was","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"211","endOffset":"222","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"ion ziprasidone was administered alone, on another occasion ","suffix":" was co-administered with oral cimetidine 800 mg and on a th","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"295","endOffset":"306","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"istered with oral cimetidine 800 mg and on a third occasion ","suffix":" was co-administered with oral Maalox®.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"47","endOffset":"58","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"The administration of cimetidine increased the ","suffix":" AUC(0, ∞) by 6% but there were no statistically significant","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"The pharmacokinetics of ","suffix":" are not affected by concurrent administration of cimetidine","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"163","endOffset":"174","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ses of cimetidine and Maalox® alter the pharmacokinetics of ","suffix":". The study protocol was approved by an independent institut","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"280","endOffset":"291","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"puter-generated randomization. These three treatments were: ","suffix":" 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and zip","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"213","endOffset":"224","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ce daily, at approximately 07.00h, commencing 2 days before ","suffix":" administration and continuing until 1 day after ziprasidone","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"273","endOffset":"284","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone administration and continuing until 1 day after ","suffix":" dosing. Maalox® suspension was administered on the evening ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"373","endOffset":"384","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"as administered on the evening before the administration of ","suffix":" (approximately 23.00 h), immediately before the ziprasidone","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"433","endOffset":"444","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone (approximately 23.00 h), immediately before the ","suffix":" dosing (approximately 09.00 h), and after lunch (approximat","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"568","endOffset":"579","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"13.00 h) and dinner (approximately 18.00 h) on the day that ","suffix":" was taken.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"45","endOffset":"56","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"Blood samples for the determination of serum ","suffix":" concentrations were collected immediately before dosing and","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"Serum concentrations of ","suffix":" were determined using high performance liquid chromatograph","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"35","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","prefix":"The maximum serum concentration of ","suffix":" (","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"92","endOffset":"103","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"dy after experiencing adverse events and only completed the ","suffix":" treatment period. Another subject discontinued the study fo","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"203","endOffset":"214","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"ntinued the study for personal reasons after completing the ","suffix":" + Maalox® and ziprasidone + cimetidine treatment periods.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"229","endOffset":"240","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"onal reasons after completing the ziprasidone + Maalox® and ","suffix":" + cimetidine treatment periods.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"15","endOffset":"26","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","prefix":"The mean serum ","suffix":" concentration–time curves for the three treatment groups we","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"11","endOffset":"22","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Mean serum ","suffix":" concentrations by treatment group (ziprasidone ◊; ziprasido","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"58","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Mean serum ziprasidone concentrations by treatment group (","suffix":" ◊; ziprasidone + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"35","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[2]","prefix":"The pharmacokinetic parameters for ","suffix":" across the three treatment groups were generally similar (","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"47","endOffset":"58","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"Individual AUC(0,∞) values by treatment group (","suffix":" ◊; ziprasidone + Maalox®▪; ziprasidone + cimetidine ▴). Gro","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"130","endOffset":"141","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"imetidine produces a small increase in systemic exposure to ","suffix":" as measured by the AUC(0,∞). Although this increase was sta","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"433","endOffset":"444","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically or clinically significant differences between the ","suffix":" + cimetidine and ziprasidone alone groups. Similarly, no st","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"462","endOffset":"473","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"ficant differences between the ziprasidone + cimetidine and ","suffix":" alone groups. Similarly, no statistically significant diffe","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"552","endOffset":"563","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"larly, no statistically significant differences between the ","suffix":" + Maalox® and ziprasidone alone groups were observed for an","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"578","endOffset":"589","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"gnificant differences between the ziprasidone + Maalox® and ","suffix":" alone groups were observed for any of the measured pharmaco","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"84","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"ignificant effects of cimetidine on the pharmacokinetics of ","suffix":" was observed despite the fact that oxidative ziprasidone me","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"141","endOffset":"152","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"of ziprasidone was observed despite the fact that oxidative ","suffix":" metabolism is primarily mediated by CYP3A4 [","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"210","endOffset":"221","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"ignificant influence on the single-dose pharmacokinetics of ","suffix":" 40 mg.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"87","endOffset":"98","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[1]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[1]/span[1]","prefix":"ris B, et al. Single- and multiple-dose pharmacokinetics of ","suffix":" in healthy young and elderly volunteers. ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"141","endOffset":"152","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[2]/span[1]","prefix":"ome P450 isoform responsible for the primary metabolites of ","suffix":" and prediction of possible drug interactions. ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[1]/h1[1]","prefix":"The pharmacokinetics of ","suffix":" in healthy volunteers treated with cimetidine or antacid","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"79","endOffset":"90","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"g subjects aged 18–45 years were given single oral doses of ","suffix":" 40 mg on three occasions at least 7 days apart. On one occa","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"155","endOffset":"166","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"g on three occasions at least 7 days apart. On one occasion ","suffix":" was administered alone, on another occasion ziprasidone was","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"211","endOffset":"222","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"ion ziprasidone was administered alone, on another occasion ","suffix":" was co-administered with oral cimetidine 800 mg and on a th","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"295","endOffset":"306","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[2]/p[1]","prefix":"istered with oral cimetidine 800 mg and on a third occasion ","suffix":" was co-administered with oral Maalox®.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"47","endOffset":"58","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[3]/p[1]","prefix":"The administration of cimetidine increased the ","suffix":" AUC(0, ∞) by 6% but there were no statistically significant","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[1]/div[4]/p[1]","prefix":"The pharmacokinetics of ","suffix":" are not affected by concurrent administration of cimetidine","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"163","endOffset":"174","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[1]","prefix":"ses of cimetidine and Maalox® alter the pharmacokinetics of ","suffix":". The study protocol was approved by an independent institut","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"280","endOffset":"291","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"puter-generated randomization. These three treatments were: ","suffix":" 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and zip","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"213","endOffset":"224","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ce daily, at approximately 07.00h, commencing 2 days before ","suffix":" administration and continuing until 1 day after ziprasidone","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"273","endOffset":"284","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone administration and continuing until 1 day after ","suffix":" dosing. Maalox® suspension was administered on the evening ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"373","endOffset":"384","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"as administered on the evening before the administration of ","suffix":" (approximately 23.00 h), immediately before the ziprasidone","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"433","endOffset":"444","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"ziprasidone (approximately 23.00 h), immediately before the ","suffix":" dosing (approximately 09.00 h), and after lunch (approximat","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"568","endOffset":"579","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[3]","prefix":"13.00 h) and dinner (approximately 18.00 h) on the day that ","suffix":" was taken.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"45","endOffset":"56","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[3]/p[1]","prefix":"Blood samples for the determination of serum ","suffix":" concentrations were collected immediately before dosing and","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"24","endOffset":"35","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[1]","prefix":"Serum concentrations of ","suffix":" were determined using high performance liquid chromatograph","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"35","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[4]/p[2]","prefix":"The maximum serum concentration of ","suffix":" (","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"92","endOffset":"103","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"dy after experiencing adverse events and only completed the ","suffix":" treatment period. Another subject discontinued the study fo","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"203","endOffset":"214","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"ntinued the study for personal reasons after completing the ","suffix":" + Maalox® and ziprasidone + cimetidine treatment periods.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"229","endOffset":"240","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[1]/p[2]","prefix":"onal reasons after completing the ziprasidone + Maalox® and ","suffix":" + cimetidine treatment periods.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"15","endOffset":"26","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[1]","prefix":"The mean serum ","suffix":" concentration–time curves for the three treatment groups we","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"11","endOffset":"22","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Mean serum ","suffix":" concentrations by treatment group (ziprasidone ◊; ziprasido","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"58","endOffset":"69","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"Mean serum ziprasidone concentrations by treatment group (","suffix":" ◊; ziprasidone + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"35","endOffset":"46","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/p[2]","prefix":"The pharmacokinetic parameters for ","suffix":" across the three treatment groups were generally similar (","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"47","endOffset":"58","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"Individual AUC(0,∞) values by treatment group (","suffix":" ◊; ziprasidone + Maalox®▪; ziprasidone + cimetidine ▴). Gro","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"130","endOffset":"141","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"imetidine produces a small increase in systemic exposure to ","suffix":" as measured by the AUC(0,∞). Although this increase was sta","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"433","endOffset":"444","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically or clinically significant differences between the ","suffix":" + cimetidine and ziprasidone alone groups. Similarly, no st","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"462","endOffset":"473","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"ficant differences between the ziprasidone + cimetidine and ","suffix":" alone groups. Similarly, no statistically significant diffe","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"552","endOffset":"563","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"larly, no statistically significant differences between the ","suffix":" + Maalox® and ziprasidone alone groups were observed for an","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"578","endOffset":"589","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"gnificant differences between the ziprasidone + Maalox® and ","suffix":" alone groups were observed for any of the measured pharmaco","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"84","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"ignificant effects of cimetidine on the pharmacokinetics of ","suffix":" was observed despite the fact that oxidative ziprasidone me","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"141","endOffset":"152","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"of ziprasidone was observed despite the fact that oxidative ","suffix":" metabolism is primarily mediated by CYP3A4 [","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"210","endOffset":"221","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"ignificant influence on the single-dose pharmacokinetics of ","suffix":" 40 mg.","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"87","endOffset":"98","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[1]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[1]/span[1]","prefix":"ris B, et al. Single- and multiple-dose pharmacokinetics of ","suffix":" in healthy young and elderly volunteers. ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"141","endOffset":"152","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[8]/div[1]/div[2]/span[1]","prefix":"ome P450 isoform responsible for the primary metabolites of ","suffix":" and prediction of possible drug interactions. ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"305","endOffset":"316","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"tion. These three treatments were: ziprasidone 40 mg alone; ","suffix":" 40 mg + cimetidine 800 mg; and ziprasidone 40 mg + Maalox® ","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"348","endOffset":"359","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[5]/div[2]/p[2]","prefix":"one 40 mg alone; ziprasidone 40 mg + cimetidine 800 mg; and ","suffix":" 40 mg + Maalox® 30 ml (aluminium hydroxide 1.35 g and magne","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"73","endOffset":"84","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":"prasidone concentrations by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"97","endOffset":"108","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[1]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴).","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"62","endOffset":"73","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":"dividual AUC(0,∞) values by treatment group (ziprasidone ◊; ","suffix":" + Maalox®▪; ziprasidone + cimetidine ▴). Group means are sh","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"86","endOffset":"97","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[6]/div[2]/div[3]/div[1]/div[2]/span[1]","prefix":" by treatment group (ziprasidone ◊; ziprasidone + Maalox®▪; ","suffix":" + cimetidine ▴). Group means are shown as horizontal dashed","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"130","endOffset":"141","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"imetidine produces a small increase in systemic exposure to ","suffix":" as measured by the AUC(0,∞). Although this increase was sta","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"433","endOffset":"444","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"istically or clinically significant differences between the ","suffix":" + cimetidine and ziprasidone alone groups. Similarly, no st","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"462","endOffset":"473","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"ficant differences between the ziprasidone + cimetidine and ","suffix":" alone groups. Similarly, no statistically significant diffe","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"0","endOffset":"11","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[3]/div[2]/span[1]","prefix":"","suffix":", aluminium, cimetidine, interaction, magnesium, pharmacokin","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"552","endOffset":"563","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"larly, no statistically significant differences between the ","suffix":" + Maalox® and ziprasidone alone groups were observed for an","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"578","endOffset":"589","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[1]","prefix":"gnificant differences between the ziprasidone + Maalox® and ","suffix":" alone groups were observed for any of the measured pharmaco","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"84","endOffset":"95","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"ignificant effects of cimetidine on the pharmacokinetics of ","suffix":" was observed despite the fact that oxidative ziprasidone me","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"141","endOffset":"152","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[2]","prefix":"of ziprasidone was observed despite the fact that oxidative ","suffix":" metabolism is primarily mediated by CYP3A4 [","exact":"ziprasidone"},{"setid":"PMC2015049","drugname":"ziprasidone","startOffset":"210","endOffset":"221","start":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","end":"/html[1]/body[1]/div[1]/div[1]/div[2]/div[1]/div[2]/div[1]/div[1]/div[3]/div[1]/div[1]/div[7]/p[3]","prefix":"ignificant influence on the single-dose pharmacokinetics of ","suffix":" 40 mg.","exact":"ziprasidone"}]]}